Local And Systemic Macrophage Activation in Coronary and Peripheral Artery Disease

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMaria Cecilia Hospital

About this trial

Numerous clinical studies have highlighted the role of macrophages in the destabilization of coronary lesions; however, there is limited literature on the relationship between circulating monocytes and intraplaque macrophages.

This study aims to evaluate and compare the presence of macrophages and their subsequent activation within coronary and peripheral atherosclerotic lesions, and to correlate these findings with the distribution of circulating monocyte subpopulations.

Eligibility criteria

Qualifiers

Patients with chronic coronary artery disease;

Patients with no-ST elevation acute coronary syndrome;

Patients with chronic claudication (Rutherford II-III)

Patients with critical limb ischemia (Rutherford IV-V).

Disqualifiers

Severe renal dysfunction

Severe valve disease

Advanced heart failure

Advanced liver disease

Trial design

Treatments tested in this trial

  • Optical Coherence Tomography assessment

Treatment groups

60 Participants
are divided into 4 treatment groups

Sponsors and collaborators